2021
DOI: 10.3389/fimmu.2021.620144
|View full text |Cite
|
Sign up to set email alerts
|

Unraveling the Role of Immune Checkpoints in Leishmaniasis

Abstract: Leishmaniasis are Neglected Tropical Diseases affecting millions of people every year in at least 98 countries and is one of the major unsolved world health issues. Leishmania is a parasitic protozoa which are transmitted by infected sandflies and in the host they mainly infect macrophages. Immunity elicited against those parasites is complex and immune checkpoints play a key role regulating its function. T cell receptors and their respective ligands, such as PD-1, CTLA-4, CD200, CD40, OX40, HVEM, LIGHT, 2B4 a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(11 citation statements)
references
References 213 publications
0
11
0
Order By: Relevance
“…Infection by protozoan parasites is associated with the production of immunoglobulin G (IgG) and immunoglobulin M (IgM). 19–21 With helminths there is, in addition, the synthesis of substantial amounts of immunoglobulin E (IgE). 22 …”
Section: Introductionmentioning
confidence: 99%
“…Infection by protozoan parasites is associated with the production of immunoglobulin G (IgG) and immunoglobulin M (IgM). 19–21 With helminths there is, in addition, the synthesis of substantial amounts of immunoglobulin E (IgE). 22 …”
Section: Introductionmentioning
confidence: 99%
“…Infected DC process parasite antigen, migrate to draining lymph nodes and prime T cells [ 2 ]. Release of IL-12 as well as other cytokines from infected DC directs Th1/Tc1 education of parasite-specific T cells [ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…As such, combining immunotherapy, specifically drugs targeting inhibitory molecules and regulatory cytokines, with drugs routinely used earlier in the process when T cell exhaustion appears could reduce the chances of VL patients acquiring resistance to conventional treatments. Such strategies have been gaining attention from the scientific and medical communities ( 124 , 178 180 ). The optimization of treatments combining typical drugs with immunotherapy might help to delay the emergence of resistance and increase the therapeutic lifespan of the respective drugs.…”
Section: Conclusion and Future Perspectivesmentioning
confidence: 99%